Faraday Pharmaceuticals
Faraday Pharmaceuticals developed iodide-based therapies for medical applications and conducted clinical trials in STEMI patients.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Pharmaceutical Manufacturing
- Founded
- 2014
- Type
- Corporation Seattle business license
- Employees
- 11–50
- Registered name
- Faraday Pharmaceuticals Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Ally.io raises $50M Series C, bringing total funding to $76M; investors include Accel, Addition, GreenOaks
Ally.io, a Seattle-based company led by co-founder & CEO Vetri Vellore, has raised $76M total with a $50M Series C as its most recent round in February 2021, backed by investors including Accel, Addition, and GreenOaks.
Fred Hutch spinout Faraday Pharmaceuticals raises $25M (up to $30M) to advance iodide drug preventing reperfusion injury and muscle loss
Faraday Pharmaceuticals, a Fred Hutch spinout, has raised $25 million (potentially up to $30 million) to develop an iodide-based drug to prevent reperfusion injury after heart attacks and ultimately limit skeletal muscle loss in stressed or bedridden patients.
Proniras launches in Seattle to develop Eli Lilly’s tezampanel, wins $89.5M BARDA contract
Proniras Corporation launched in Seattle to develop tezampanel, a seizure drug originally created by Eli Lilly, and secured an $89.5 million BARDA contract contingent on development milestones. The company also received undisclosed launch funding from several investors, will be led by co-founder and CSO Chris Toombs, and plans to explore tezampanel as both a seizure therapy and a nerve-agent antidote.
Online
Questions about Faraday Pharmaceuticals
What is Faraday Pharmaceuticals?
Faraday Pharmaceuticals is a former startup based in Seattle, Washington, US, that developed iodide-based therapies for medical applications and conducted clinical trials in STEMI patients.
What has Faraday Pharmaceuticals been in the news for?
GeekWire reported in September 2019 that Faraday Pharmaceuticals was a Fred Hutch spinout advancing an iodide drug to prevent reperfusion injury and muscle loss.
Who invested in Faraday Pharmaceuticals, and how much has it raised?
Members of Seattle Flow see Faraday Pharmaceuticals' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Faraday Pharmaceuticals based?
Faraday Pharmaceuticals is based in Seattle, Washington, US.
When was Faraday Pharmaceuticals founded?
Faraday Pharmaceuticals was founded in 2014.
How many people work at Faraday Pharmaceuticals?
Faraday Pharmaceuticals has 11–50 employees.